These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 12626128

  • 1. A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952.
    Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP.
    Neuro Oncol; 2003 Jan; 5(1):8-13. PubMed ID: 12626128
    [Abstract] [Full Text] [Related]

  • 2. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.
    Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie-Cardine A, Luporsi E, Margueritte G, Lejars O, Laithier V, Mechinaud F, Millot F, Kalifa C, Chastagner P.
    Cancer; 2005 Dec 15; 104(12):2792-7. PubMed ID: 16265674
    [Abstract] [Full Text] [Related]

  • 3. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1182-5. PubMed ID: 12654425
    [Abstract] [Full Text] [Related]

  • 4. Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study.
    Bradley KA, Zhou T, McNall-Knapp RY, Jakacki RI, Levy AS, Vezina G, Pollack IF.
    Int J Radiat Oncol Biol Phys; 2013 Jan 01; 85(1):e55-60. PubMed ID: 23092726
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic combination therapy after local radiotherapy with topotecan radiosensitizer improved quality of life for children with inoperable brainstem gliomas.
    Kivivuori SM, Riikonen P, Valanne L, Lönnqvist T, Saarinen-Pihkala UM.
    Acta Paediatr; 2011 Jan 01; 100(1):134-8. PubMed ID: 20712831
    [No Abstract] [Full Text] [Related]

  • 6. A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies.
    Forouzannia A, Schiller J, Berlin J, Hutson P, Boothman D, Storer B, Wilding G, Mehta M.
    Lung Cancer; 2004 Apr 01; 44(1):111-9. PubMed ID: 15013589
    [Abstract] [Full Text] [Related]

  • 7. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
    Haas-Kogan DA, Banerjee A, Kocak M, Prados MD, Geyer JR, Fouladi M, McKnight T, Poussaint TY, Broniscer A, Blaney SM, Boyett JM, Kun LE.
    Neuro Oncol; 2008 Jun 01; 10(3):341-7. PubMed ID: 18417739
    [Abstract] [Full Text] [Related]

  • 8. A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer.
    Agelaki S, Kontopodis E, Kotsakis A, Chandrinos V, Bompolaki I, Zafeiriou Z, Papadimitraki E, Stoltidis D, Kalbakis K, Georgoulias V.
    Cancer Chemother Pharmacol; 2013 Jul 01; 72(1):45-51. PubMed ID: 23604531
    [Abstract] [Full Text] [Related]

  • 9. Phase I study of topotecan and radiation therapy in advanced cervical cancer.
    Dunton CJ, King SA, Neufeld J, Tolosa J, Perez G, Avila A, Underhill K.
    Gynecol Oncol; 2002 Apr 01; 85(1):185-7. PubMed ID: 11925142
    [Abstract] [Full Text] [Related]

  • 10. Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and LeukemiaGroup B study.
    Lilenbaum RC, Miller AA, Batist G, Bernard S, Hollis DR, Rosner GL, Egorin MJ, Schilsky RL, Ratain MJ.
    J Clin Oncol; 1998 Oct 01; 16(10):3302-9. PubMed ID: 9779705
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
    Miller AA, Hargis JB, Lilenbaum RC, Fields SZ, Rosner GL, Schilsky RL.
    J Clin Oncol; 1994 Dec 01; 12(12):2743-50. PubMed ID: 7527456
    [Abstract] [Full Text] [Related]

  • 12. Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.
    Wagner S, Erdlenbruch B, Längler A, Gnekow A, Kühl J, Albani M, Völpel S, Bucsky P, Emser A, Peters O, Wolff JE.
    Cancer; 2004 Apr 15; 100(8):1750-7. PubMed ID: 15073866
    [Abstract] [Full Text] [Related]

  • 13. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
    Korones DN, Fisher PG, Kretschmar C, Zhou T, Chen Z, Kepner J, Freeman C.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):227-30. PubMed ID: 17278121
    [Abstract] [Full Text] [Related]

  • 14. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
    Miller AA, Al Omari A, Murry DJ, Case D.
    Lung Cancer; 2006 Dec 15; 54(3):379-85. PubMed ID: 17049403
    [Abstract] [Full Text] [Related]

  • 15. Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.
    Garces YI, Okuno SH, Schild SE, Mandrekar SJ, Bot BM, Martens JM, Wender DB, Soori GS, Moore DF, Kozelsky TF, Jett JR.
    Int J Radiat Oncol Biol Phys; 2007 Mar 15; 67(4):995-1001. PubMed ID: 17336213
    [Abstract] [Full Text] [Related]

  • 16. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
    Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM.
    Neuro Oncol; 2007 Apr 15; 9(2):145-60. PubMed ID: 17293590
    [Abstract] [Full Text] [Related]

  • 17. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P.
    Cancer; 2002 Oct 01; 95(7):1511-9. PubMed ID: 12237920
    [Abstract] [Full Text] [Related]

  • 18. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
    Pentheroudakis G, Briasoulis E, Karavassilis V, Mauri D, Tzamakou E, Rammou D, Pavlidis N.
    Chemotherapy; 2005 May 01; 51(2-3):154-61. PubMed ID: 15886476
    [Abstract] [Full Text] [Related]

  • 19. Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies.
    Posey JA, Wang H, Hamilton J, Delgrosso A, Zhang R, Freda T, Zamboni WC.
    Cancer Chemother Pharmacol; 2005 Aug 01; 56(2):182-8. PubMed ID: 15838660
    [Abstract] [Full Text] [Related]

  • 20. Phase II evaluation of topotecan for pediatric central nervous system tumors.
    Blaney SM, Phillips PC, Packer RJ, Heideman RL, Berg SL, Adamson PC, Allen JC, Sallan SE, Jakacki RI, Lange BJ, Reaman GH, Horowitz ME, Poplack DG, Balis FM.
    Cancer; 1996 Aug 01; 78(3):527-31. PubMed ID: 8697400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.